Lamifin-M Cream is a topical formulation combining Mometasone furoate (0.1% w/w), a potent corticosteroid, with Terbinafine hydrochloride (1% w/w), an effective antifungal agent. This combination is indicated for the treatment of inflammatory dermatoses complicated by fungal infections, such as tinea corporis, tinea cruris, and tinea pedis, where both inflammation and fungal proliferation coexist. Mometasone exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by inhibiting the release of inflammatory mediators and suppressing immune responses, thereby reducing redness, swelling, and itching. Terbinafine, an allylamine antifungal, acts by inhibiting squalene epoxidase, an essential enzyme in ergosterol synthesis, leading to fungal cell membrane disruption and cell death. Lamifin-M Cream should be applied topically to the affected area once or twice daily as directed by a healthcare professional. It is important to use the medication for the prescribed duration to prevent recurrence and resistance. Caution is advised in patients with hypersensitivity to any components, and prolonged use should be avoided to minimize potential corticosteroid-related adverse effects such as skin atrophy or systemic absorption. Lamifin-M Cream offers a dual-action approach for effective management of inflammatory fungal skin conditions.